Renal Risk-Benefit Determinants of Recombinant Human Erythropoietin Therapy in the Remnant Kidney Rat Model - Hypertension, Anaemia, Inflammation and Drug Dose
AuthID
P-00K-7Q1
P-00K-7Q1
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service